Beam TherapeuticsInc Z Score
BEAM  Stock  USD 44.10 0.92 2.13% 
Beam TherapeuticsInc  Z Score 
Beam TherapeuticsInc Z Score Analysis
Beam TherapeuticsInc's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..Current Beam TherapeuticsInc Z Score  10.2 
Most of Beam TherapeuticsInc's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beam TherapeuticsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Beam TherapeuticsInc Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Beam TherapeuticsInc is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Beam TherapeuticsInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Beam TherapeuticsInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Beam TherapeuticsInc's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
In accordance with the company's disclosures, Beam TherapeuticsInc has a Z Score of 10.2. This is 51.11% higher than that of the Biotechnology sector and 205.39% higher than that of the Health Care industry. The z score for all United States stocks is 16.97% lower than that of the firm.
Beam TherapeuticsInc Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beam TherapeuticsInc's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Beam TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Beam TherapeuticsInc by comparing valuation metrics of similar companies.Beam TherapeuticsInc is currently under evaluation in z score category among related companies.
Beam TherapeuticsInc Fundamentals
Return On Equity  (0.40) %  
Return On Asset  (0.08) %  
Operating Margin  (1.72) %  
Current Valuation  2.38 B  
Shares Outstanding  70.47 M  
Shares Owned by Insiders  1.85 %  
Shares Owned by Institutions  87.06 %  
Number of Shares Shorted  13.01 M  
Price to Earning  37.48 X  
Price to Book  4.38 X  
Price to Sales  33.09 X  
Revenue  51.84 M  
Gross Profit  (180.29 M)  
EBITDA  (363.19 M)  
Net Income  (370.64 M)  
Cash and Equivalents  1.09 B  
Cash per Share  15.90 X  
Total Debt  3.01 M  
Debt to Equity  0.25 %  
Current Ratio  4.64 X  
Book Value Per Share  10.38 X  
Cash Flow from Operations  (66.27 M)  
Short Ratio  13.39 X  
Earnings Per Share  (3.59) X  
Price to Earnings To Growth  (2.30) X  
Target Price  80.08  
Number of Employees  507  
Beta  1.63  
Market Capitalization  3.04 B  
Total Asset  1.47 B  
Retained Earnings  (208.39 M)  
Working Capital  2.18 B  
Current Asset  2.89 B  
Current Liabilities  706.6 M  
Z Score  10.2  
Net Asset  1.47 B 
About Beam TherapeuticsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beam TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beam TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beam TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. Beam Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 507 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Beam TherapeuticsInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account 
All Next  Launch Module 
Pair Trading with Beam TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Beam TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Beam TherapeuticsInc
+  0.85  EDIT  Editas Medicine  Buyout Trend  PairCorr  
+  0.73  HRTX  Heron Therapeuti  Buyout Trend  PairCorr 
Moving against Beam TherapeuticsInc
  0.55  GILD  Gilead Sciences  Selloff Trend  PairCorr 
The ability to find closely correlated positions to Beam TherapeuticsInc could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Beam TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Beam TherapeuticsInc  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Beam TherapeuticsInc to buy it.
The correlation of Beam TherapeuticsInc is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Beam TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Beam TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Beam TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Continue to Beam TherapeuticsInc Piotroski F Score and Beam TherapeuticsInc Valuation analysis. Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with precomputed micro ideas to build optimal portfolio .
Complementary Tools for Beam TherapeuticsInc Stock analysis
When running Beam TherapeuticsInc price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets  Go  
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges  Go  
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk  Go  
Financial WidgetsEasily integrated Macroaxis content with over 30 different plugandplay financial widgets  Go  
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios  Go  
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings  Go  
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios.  Go  
Stock TickersUse highimpact, comprehensive, and customizable stock tickers that can be easily integrated to any websites  Go  
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios  Go  
Global CorrelationsFind global opportunities by holding instruments from different markets  Go 
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam TherapeuticsInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization 3 B  Quarterly Revenue Growth YOY 19.706  Return On Assets (0.08)  Return On Equity (0.40) 
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam TherapeuticsInc that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Beam TherapeuticsInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.